Ed Septimus | Medical Director of Infection Prevention and Epidemiology
H.C.A.

Ed Septimus, Medical Director of Infection Prevention and Epidemiology, H.C.A.

Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston in 1972.  Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. Dr. Ed Septimus is board certified in both internal medicine and infectious diseases.  His was VP Research and Infectious Diseases Hospital Corporation of America (HCA).  He has served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and was on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee.   He was the first recipient of the IDSA Annual Clinician Award.  In 2011 he was appointed to the Healthcare-Associated Infections/Preventable Adverse Events Advisory Panel for the Texas Department of State Health Services.  He was awarded the John S Dunn Sr. Outstanding Teacher Award in 2010, 2011, 2013, 2014, and 2016.  He is on the FDA Anti-Infective Drug Advisory Group and is co-chair of the NQF Patient Safety Steering Committee. He holds a faculty position as Clinical Professor at Texas A&M Medical School and Professor, Distinguished Senior Fellow, School of Public Health, George Mason University and Senior Lecturer Department Population Medicine Harvard Medical School.  He has published over 100 articles and chapters.

Appearances:



World Anti-Microbial Resistance Congress USA 2018 - Day 1 @ 16:10

Panel - Hospital Antibiotic Stewardship programs – Challenges in infrastructure, education and data collection

  • What is working in hospital ASPs today?
  • How do different funding structures impact stewardship efforts and what needs to change to continue to ASPs
  • Recommendations to advance both in-patient and out-patient stewardship programs
  • What technological advancements do hospitals need in order to monitor and reduce use of antibiotics in both in-patient and out-patient settings
last published: 11/Oct/18 18:25 GMT

back to speakers